Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
Andreas BeyerleinEzio BonifacioKendra VehikMarkus HippichChristiane WinklerBrigitte I FrohnertAndrea K SteckWilliam A HagopianJeffrey P KrischerÅke LernmarkMarian J RewersJin-Xiong SheJorma ToppariBeena AkolkarStephen S RichAnette-G Zieglernull nullPublished in: Journal of medical genetics (2018)
Genetic risk scores may be used to identify islet autoantibody-positive children with high-risk HLA genotypes who have a slow rate of progression to subsequent stages of autoimmunity and type 1 diabetes.